With 100 Million CAD in Funding, LEO Innovation Lab Plans to Build Innovative Technology Solutions and Collaborate With Startups to Improve the Lives of People Living With Psoriasis
MARKHAM, ON–(Marketwired – January 27, 2016) – LEO Pharma, Denmark’s oldest healthcare company, announced today the launch of its first innovation lab in North America. Backed by $100M CDN in funding, LEO Innovation Lab will develop new, non-pharmaceutical solutions for people living with psoriasis and partner with the startup community to foster innovation in apps, web platforms, wearables, virtual reality, artificial intelligence, tele-medicine and other advanced technologies. Located north of Toronto in Markham, LEO Innovation Lab is LEO Pharma’s first innovation venture outside of Europe. Similar innovation labs today operate in Copenhagen, London and Paris.